Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 192-201, 2006. First published December 29, 2005; 10.1373/clinchem.2005.059766
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplements
Right arrow All Versions of this Article:
clinchem.2005.059766v1
52/2/192    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garrido, P.
Right arrow Articles by Parro, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garrido, P.
Right arrow Articles by Parro, V.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2006;52:192-201.)
© 2006 American Association for Clinical Chemistry, Inc.


Molecular Diagnostics and Genetics

STEC-EPEC Oligonucleotide Microarray: A New Tool for Typing Genetic Variants of the LEE Pathogenicity Island of Human and Animal Shiga Toxin–Producing Escherichia coli (STEC) and Enteropathogenic E. coli (EPEC) Strains

Patricia Garrido1, Miguel Blanco2, Mercedes Moreno-Paz1, Carlos Briones1, Ghizlane Dahbi2, Jesús Blanco2, Jorge Blanco2 and Víctor Parro1,a

1 Laboratorio de Ecología Molecular, Centro de Astrobiología (INTA-CSIC), Madrid, Spain.
2 Laboratorio de Referencia de E. coli (LREC), Departamento de Microbiología y Parasitología, Facultad de Veterinaria, Universidad de Santiago de Compostela, Lugo, Spain.

aAddress correspondence to this author at: Laboratorio de Ecología Molecular, Centro de Astrobiología (INTA-CSIC), carretera de Ajalvir km 4, 28850, Torrejón de Ardoz, Madrid, Spain. Fax 34-915201074; e-mail parrogv{at}inta.es.


   Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Background: Shiga toxin–producing Escherichia coli (STEC) and enteropathogenic E. coli (EPEC) are important emerging pathogens that can cause a severe and sometimes fatal illness. Differentiation of eae, tir, espA, espD, and espB gene variants of the locus of enterocyte effacement (LEE) pathogenicity island represents an important tool for typing in routine diagnostics as well as in pathogenesis, epidemiologic, clonal, and immunologic studies.

Methods: Type-specific oligonucleotide microarrays and a PCR scheme were designed and constructed for the detection and typing of genetic variants of the LEE genes. Oligonucleotide probes were tested for their specificity against the corresponding type strain by microarray hybridization using fluorescent DNA, either PCR-amplified (single, multiplex, long-range), chromosomal, or amplified chromosomal DNA.

Results: The PCR scheme and the oligonucleotide microarray allowed us to distinguish 16 variants ({alpha}1, {alpha}2, ß1, ß2, {gamma}1, {gamma}2/{theta}, {delta}/{kappa}, {epsilon}, {zeta}, {eta}, {iota}, {lambda}, µ, {nu}, {xi}, o) of the eae gene, 4 variants ({alpha}1, ß1, {gamma}1, {gamma}2/{theta}) of the tir gene, 4 variants ({alpha}1, ß1, ß2, {gamma}1) of the espA gene, 3 variants ({alpha}1, ß1, {gamma}1) of the espB gene, and 3 variants ({alpha}1, ß1, {gamma}1) of the espD gene. We found a total of 12 different combinations of tir, espA, espB, and espD genes among the 25 typed strains.

Conclusions: The PCR scheme and the oligonucleotide microarray described are effective tools to rapidly screen multiple virulence genes and their variants in E. coli strains isolated from human and animal infections. The results demonstrate the great genetic diversity among LEE genes of human and animal STEC and EPEC strains.


   Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Shiga toxin–producing Escherichia coli (STEC) 1 are important emerging pathogens that can cause a severe and sometimes fatal illness. STEC produce 2 potent cytotoxins called Shiga toxins, Stx1 and Stx2 (1)(2)(3)(4)(5)(6)(7)(8)(9). In contrast to STEC, enteropathogenic E. coli (EPEC) strains do not produce Shiga toxins. EPEC strains are a major cause of infant diarrhea in developing areas of the world and are pathogenic to several animal species (rabbits, calves, dogs, primates, sheep, and pigs) (10)(11)(12)(13)(14)(15)(16)(17)(18). Both STEC and EPEC cause characteristic attaching and effacing (A/E) lesions in the intestinal mucosa, so that they are also called A/E E. coli (14)(15)(19)(20)(21)(22). The A/E lesion consists of intimate attachment of the bacteria to the enterocyte membrane and effacement of the microvilli of the cell. A pedestal-like structure is formed via accumulation of polymerized actin filaments beneath the adhered bacteria (23). A large chromosomal pathogenicity island, the locus of enterocyte effacement (LEE) (22)(24)(25), is the genetic determinant for A/E lesions. In general and for functional purposes, the STEC and EPEC LEE genes are divided into 3 regions (22)(26)(27): The middle region contains the eae (encoding intimin, a 94- to 97-kDa outer membrane protein), cesT, and tir (encoding the intimin receptor) genes. The second region is located upstream of the eae/tir domain and encodes a type III secretion system, the type III secreted effector proteins, and several regulators of the LEE island. The third region, located downstream of the eae/tir domain, encodes other type III secreted proteins (EspA, EspB, and EspD) and components of the type III secretion system. Tir, EspB, and probably EspD are translocated into the host cells through the translocation machinery formed by some components of the type III secretion system and EspA. The translocated EspB and EspD proteins are integrated into the cytoplasmic membrane of the target cells and may form a pore that allows other molecules to enter these cells (22)(25)(28)(29)(30).

Differences in length, insertion sites, or nucleotide sequences have been found in the LEE region. Moreover, specific variants of intimin are related to STEC strains pathogenic for humans, whereas other intimin variants are related to human or animal EPEC strains (19)(31)(32). The N-terminal end of intimin is well conserved, whereas the C-terminal end is highly variable and is responsible for receptor binding. It has been suggested that differences in host tissue cell tropism may be attributable to different intimin types (33)(34). For example, intimin {gamma}1 from STEC O157:H7 seems to restrict colonization to Peyer’s patches of the human intestine (35). Adu-Bobie et al. (19) found that antigenic variation exists within the cell-binding domain of intimin types expressed by different clinical human EPEC and STEC isolates. Using specific oligonucleotide primers complementary to the 3'-end eae genes, they defined 4 intimin types ({alpha}, ß, {gamma}, and {delta}) by type-specific PCR (TS-PCR) assays. In another molecular study, Oswald et al. (31) described a TS-PCR assay that identifies a fifth intimin variant (intimin {epsilon}). They divided the intimin alleles {alpha}, ß, and {gamma} based on PCR–restriction fragment length polymorphism profiles into {alpha}1, {alpha}2, {gamma}1, and {gamma}2 subtypes. Tarr and Whittam (36) described 2 new types ({zeta} and {theta}) in a work on the molecular evolution of intimin genes in human STEC and EPEC O111 clones. Recently, Zhang et al. (32) determined the sequences of 3 new intimin variant genes ({kappa}, {eta}, and {iota}) found in human STEC strains. They recommended TS-PCR protocols for detection of these types of eae genes and performed a phylogenetic analysis. The sequence of the 3' variable region of eae gene of a new intimin ({lambda}) has been submitted to GenBank by B. China (GenBank accession no. AF439538), and we sequenced the whole intimin {lambda} gene from a human strain (GenBank accession no. AJ715409). Blanco et al. [Ref. (11) and unpublished results] identified 3 new intimin genes in human EPEC strains (intimin ß2, µ, and {nu}) and 1 in bovine STEC strains (intimin {xi}). Like Zhang et al. (32), we have observed that the sequences of the eae-{gamma}2 gene defined by Oswald et al. (31) and the eae-{theta} gene described by Tarr and Whittam (36) are almost identical (99%). These 2 sequences should be considered as a single eae variant ({gamma}2/{theta}). We have also observed that the eae-{kappa} gene recently described by Zhang et al. (32) has a sequence very similar (99%) to that of the eae-{delta} gene defined by Adu-Bobie et al. (19); therefore, these 2 sequences should be considered a single eae variant ({delta}/{kappa}). Furthermore, because of the high degree of sequence identity, specific primers could not be designed for distinguishing eae-{gamma}2 and eae-{theta} genes or for differentiating eae-{delta} and eae-{kappa} genes. In addition to the eae gene, variants in the tir ({alpha}, ß, {gamma}, and {theta}), espA ({alpha}, ß, and {gamma}), espB ({alpha}, ß, and {gamma}), and espD ({alpha}, ß, {gamma}) genes have also been described, whereas the esc and sep genes are more conserved (29)(31)(37)(38). The nomenclature for tir, espA, espB, and espD genes follows the same principle as that for eae, as described China et al. (37). Currently, only associations between the tir, espA, espB, and espD genes with 7 different types of intimin ({alpha}1, ß1, {gamma}1, {gamma}2/{theta}, {delta}, {epsilon}, and {zeta}) have been studied in EPEC and STEC strains.

Thus, differentiation of eae, tir, and esp alleles is an important tool for STEC and EPEC typing in routine diagnostics as well as in epidemiologic and clonal studies. The fact that the 5' regions of eae genes are conserved whereas the 3' regions are heterogeneous has permitted the design of universal and allele-specific PCR primers to differentiate among 16 variants of the eae gene encoding 16 different intimin types and subtypes: {alpha}1, {alpha}2, ß1, ß2, {gamma}1, {gamma}2/{theta}, {delta}/{kappa}, {epsilon}, {zeta}, {eta}, {iota}, {lambda}, µ, {nu}, {xi}, and o [Refs. (4)(19)(31)(32)(39) and this study]. Genetic diversity was also found in other LEE genes (29)(37)(38). In this work, we describe 4 variants ({alpha}1, ß1, {gamma}1, and {gamma}2) of the tir gene, 4 variants ({alpha}1, ß1, ß2, and {gamma}1) of the espA gene, 3 variants ({alpha}1, ß1, and {gamma}1) of the espB gene, and 3 variants ({alpha}1, ß1, {gamma}1) of the espD gene. We also establish a total of 12 different combinations or associations between the tir, espA, espB, and espD genes.

Although molecular methods such as PCR, multiplex PCR, and real-time PCR have been used to detect and identify pathogenic E. coli strains, an important limitation is the existence of a large number of virulence factors as well as a high allelic variation (4)(37)(40)(41). This makes PCR assessment of any single isolate for all known virulence genes and variants very laborious. Microarray technology allows assessment of hundreds of different genes and variants from a particular strain as well as comparative analysis between strains. Several studies have been reported that used DNA microarrays as a diagnostic tool (21)(40)(41)(42)(43)(44)(45)(46)(47)(48). Bekal et al. (49) presented a DNA microarray for pathotype identification, using PCR-amplified fragment from 91 E. coli virulence genes as immobilized probes. These PCR fragments work very well when the target genes are quite different in sequence, but they can produce cross-hybridization events between highly similar gene variants.

The growing allelic variance at the LEE island requires more precision during the design of a DNA microarray. PCR fragments are not appropriate as probes because of the high degree of sequence identity between alleles of the same gene. In this work, we designed and constructed an oligonucleotide microarray to detect specifically most of the known alleles of the LEE-encoded tir, eae, espA, espD, and espB genes. Each specific probe on the microarray has been checked and validated against its corresponding type strain, with fluorescently labeled PCR-amplified DNA used as target. We also present a comparison between different methods for target labeling: single PCR, multiplex PCR, long-range PCR (LR-PCR), chromosomal DNA, and multiple displacement amplification (MDA)-amplified chromosomal DNA.


   Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
bacterial strains
The 25 human and animal STEC and EPEC strains used in this study were part of the culture collection of the Laboratorio de Referencia de E. coli (Lugo, Spain;http://www.lugo.usc.es/ecoli ). Some strains were provided by L.G. Giugliano (Brasília, Brazil; strain 68-4), F. Schelotto and G. Varela (Montevideo, Uruguay; strains EPEC-359/FV359 and FV380), F. Ørskov and I. Ørskov (Copenhagen, Denmark; strains EPEC-8/Aberdeen 1064, EPEC-4/F41, and EPEC-9/BP12665), H. Schmidt (Wüzburg, Germany; strains 6044-95 and 7476/96/FV3676), H. Karch (Münster, Germany; strain EPEC-2348III), E. Oswald (Tolouse, France; strain CF11201/FV3671), Y. Bertin (Clermont-Ferrand-Theix, France; strain EDL933), and T.S. Whittam (Michigan; strain TW07926). The 25 E. coli strains used in this work are listed in Table 1 , and they are control strains (type strains) for the 16 different intimin types and subtypes. Strains were stored at room temperature in nutrient broth containing 7.5 g/L agar. E. coli K-12 MG1655, a non-LEE pathogenicity island–containing strain, was used as negative control.


View this table:
[in this window]
[in a new window]
 
Table 1. Serotypes and virulence genes of the strains characterized in this study: Results of the typing of lee genes by PCR.

serotyping
We used the method described by Guinée et al. (50) to determine the O and H antigens, using all available O (O1–O185) and H (H1–H56) antisera. All antisera were obtained and adsorbed with the corresponding cross-reacting antigens to remove the nonspecific agglutinins. The O antisera were produced in the Laboratorio de Referencia de E. coli, and the H antisera were obtained from the Statens Serum Institut (Copenhagen, Denmark).

pcr primers and oligonucleotide probes
PCR primers and oligonucleotide probes for the different variants of the tir, eae, espA, espD, and espB genes were designed and synthesized (after sequence alignment, by Clustal W software, from the GenBank sequences) or taken from previous works (see Tables 2 and 3 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol52/issue2 ). For microarrays, probes were synthesized with a 5' C6 amino linker followed by a (dT)10 tail and the specific sequence (from 18 to 25 nucleotides). Probe design was done so that the mismatched positions were located in the central region of the oligonucleotides to increase the hybrid instability with sequences from other strains. All probes were selected for similar melting point temperatures so that all assays could be performed under the same experimental conditions.

pcr typing of lee genes and detection of other virulence genes
The methodology used for PCR typing of the eae, tir, espA, espD, and espB genes and PCR detection of the stx1, stx2 and bfpA virulence genes has been described elsewhere (4)(51)(52). Nucleotide sequences and predicted sizes of the amplified products for the specific eae, tir, espA, espB, espD, stx1, stx2, and bfpA oligonucleotide primers used in this study are shown in Table 1 of the online Data Supplement.

dna preparation, pcr amplification, and labeling
Genomic DNA from the strains listed in Table 1Up was extracted from overnight cultures by use of a commercial DNA preparation reagent set (Gnome; Q-BIOgene). All strains were rechecked by PCR amplification with specific oligonucleotides (see Table 1 in the online Data Supplement) and sequencing of the corresponding gene fragment (not shown). Fluorescent labeling of each gene variant shown in Table 1 in the online Data Supplement was carried out by PCR as follows: 50-µL total volume containing 1 µg of each bacterial strain DNA (see Table 1 in the online Data Supplement) as template; 3 mM MgCl2; 100 µM each of dATP, dCTP, and dGTP; 50 µM dTTP; 50 µM Cy5-dUTP (Amersham Biosciences), 200 µM each of forward and reverse primers, and 1 U of Platinum Taq DNA polymerase in its reaction buffer (Invitrogen).

For the eae-{alpha}1, -{alpha}2, -{delta}, -{epsilon}, -{gamma}1, -{gamma}2, -{eta}, -{iota}, -{lambda}, -µ, -{nu}, -o, -{xi}, and -{zeta} gene variants, the forward primer was EAE-1 and the reverse primers were EAE-A, EAE-A2R, EAE-D3R, EAE-ep2R, EAE-C1, EAE-C2, EAE-et2R, LP-7, EAE-L2R, FV373-R, EAE-N2R, IH2997f-R, EAE-RB, and EAE-Z2R, respectively. For eae-ß1 and -ß2, the forward primer was EAE-F and the reverse primers were EAE-B8R and EAE-B5R, respectively. The primer pairs TIR-I1F/TIR-I1R, TIR-II1F/TIR-II1R, TIR-III1F/TIR-III1R, and TIR-IV1F/TIR-IV1R were used for tir-{alpha}1, -ß1, -{gamma}1, and -{gamma}2, respectively. For espA-{alpha}1, -ß1, -ß2, and -{gamma}1, ESPA-1 was the forward and ESPA-I1R, ESPA-II1R, ESPA-III1R, and ESPA-IV1R were the respective reverse primers; for espB-{alpha}1, -ß1, and -{gamma}1, ESPB-F was the forward primer and ESPB-I1R, ESPB-II1R, and ESPB-III1R were the respective reverse primers; and for espD-{alpha}1, -ß1, and -{gamma}1, ESPD-4F was the forward and ESPD-I1R, ESPD-II1R, and ESPD-III1R were the respective reverse primers. For all cases but eae-ß1 and -ß2, the thermocycler was programmed as follows: 1 cycle of 5 min at 95 °C; 10 cycles of 20 s at 95 °C, 30 s at 60 °C, and 1.5 min at 68 °C; 30 cycles of 20 s at 95 °C, 30 s at 58 °C, and 1.5 min + 5 s/cycle at 68 °C; 1 cycle of 10 min at 68 °C; and a hold at 4 °C. For eae-ß1 and -ß2, the annealing temperature was lowered to 55 °C during the 10 first cycles and 53 °C for the remaining 30 cycles. Once checked on agarose gels, PCR products were purified from the unincorporated nucleotides by use of PCR purification reagents from Qiagen. We checked the labeling efficiency by measuring the absorbance at 260 nm (for DNA) and 635 nm (for Cy5) in a NanoDrop ND-1000TM spectrometer (NanoDrop Technologies).

multiplex pcr, lr-pcr, and labeling
For simultaneous multiplex PCR and labeling of the tir, eae, espA, espD, and espB genes from strains FV3671 and FV3676, we used the following conditions: primer pairs EAE-F/EAEet-2R for eae-{eta} (eta) in strain FV3671; EAE-F/LP7 for eae-{iota} (iota) in strain FV3676; ESPA1/ESPAII-1R for espA-ß1 in FV3671; ESPA1/ESPAI-1R for espA-{alpha}1 in FV3676; and TIR-A/TIR-B, ESPB-F/ESPBI-1R, and ESPD-4F/ESPDI-1R for the tir-{alpha}1, espB-{alpha}1, and espD-{alpha}1 genes, respectively, in both strains. The PCR reaction volume was 50 µL, with the same buffer and components used as above; the final concentrations of each primer was 200 µM. The thermocycler was set at 1 cycle of 5 min at 95 °C; 10 cycles of 20 s at 95 °C, 30 s at 50 °C, and 1 min at 68 °C; 25 cycles of 20 s at 95 °C, 30 s at 48 °C, and 1 min + 5 s/cycle at 68 °C; 1 cycle of 10 min at 68 °C; and a hold at 4 °C. PCR products, purification, and labeling efficiency were checked as above.

Amplification and labeling of the whole tir-eae-espA-espD-espB gene cluster (~10 kbp) were carried out by LR-PCR using the universal pair of primers TIR-UP (5'-TGATTAATCATGGCAAACTGACTA-3') and ESPB-DOWN (5'-CACTGCCACAAAGAAACTCCTTC-3') in a 50-µL (total volume) reaction. The reaction contained 500 µM each of dATP, dCTP, and dGTP; 250 µM dTTP; 50 µM Cy5-dUTP; 300 µM each of the primers; and 3.5 U of the Expand-Long Template DNA polymerase (Roche) in the supplied reaction 1x buffer. The thermocycler was programmed as follows: 1 cycle of 5 min at 95 °C; 15 cycles of 20 s at 95 °C, 30 s at 55 °C, and 10 min at 68 °C; 30 cycles of 20 s at 95 °C, 30 s at 55 °C, and 10 min + 20 s/cycle at 68 °C; 1 cycle of 10 min at 68 °C; and a hold at 4 °C. PCR products, purification, and labeling efficiency were checked as above.

genomic dna labeling
Genomic DNA was fluorescently labeled as follows: DNA (60 µL at 100 ng/µL in 10 mmol/L Tris-HCl, pH 8) was fragmented by ultrasonication by immersion of an Eppendorf tube containing the sample for 10 s at maximum power in the water bath on the "cup horn" of a MISONIX XL2010 sonicator. Under these conditions, we obtained fragments 1 to 4 kbp in length (the majority around 2.5 kbp), which were used for random priming labeling with Klenow DNA polymerase. The reaction mixture containing 2 µg of denatured DNA; 120 µmol/L each of dATP, dCTP, and dGTP; 60 µmol/L dTTP; 60 µmol/L Cy5-dUTP; 50 ng/µL random hexamers; and 50 U of Klenow enzyme (New England Biolabs) in its supplied 1x reaction buffer was incubated at 37 °C for 1–2 h. The reaction was stopped by addition of 5 µL of 0.5 mol/L EDTA, and the DNA was purified and checked for labeling efficiency as above.

genomic dna amplification
For genomic DNA amplification by MDA, 1 and 10 pg of bacterial DNA were subjected to amplification with Genomiphi system (Amersham Biosciences). Usually, more than 10 µg of amplified DNA was obtained. Up to 2 µg of this DNA was sonicated for 10 s and labeled as indicated above.

microarray production, hybridization assays, and analysis
Oligonucleotide probes, 60 µmol/L in spotting buffer (TeleChem International), were printed on epoxy-activated glass slides (TeleChem International) by use of a Microgrid II arrayer (BioRobotics; Genomic Solutions). Ten minutes after spotting, the slides were collected and stored at room temperature until used, as recommended by the manufacturer. Microarrays were prehybridized with 20 µL of 5x standard saline citrate containing 1 g/L sodium dodecyl sulfate, 0.1 g/L herring sperm DNA, and 10 g/L bovine serum albumin at 42 °C for 30–40 min. Slides were washed in distilled water, submerged in isopropanol, dried by centrifugation, and hybridized with 15–20 µL of fluorescently labeled DNA. Both PCR fragments and chromosomal DNA were denatured for 5 min at 95 °C and set to hybridize on the microarray under a cover slide (HybriSlip; Gracebio) in a hybridization chamber at 55 °C for 12 h. Printing and hybridization (Hybit) buffers and hybridization chambers were from TeleChem International. Slides were washed at room temperature twice for 5 min each in 2x standard saline citrate containing 1 g/L sodium dodecyl sulfate, twice for 5 min each in 0.2x standard saline citrate containing 1 g/L sodium dodecyl sulfate, and twice for 5 min each in 0.2x standard saline citrate; slides were then dried by centrifugation and scanned in a GMS 418 Array Scanner (Affymetrix). Images were analyzed and the spot signal was quantified by Genepix software (Genomics Solutions). The spot intensities are given in arbitrary units (0–65 000) as obtained from the Genepix software.


   Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
pcr typing of lee genes: designation of universal and specific primers
Primers for detection of all variants of eae, tir, espA, espB, and espD gene sequences, published or submitted to EMBL/GenBank/DDBJ Nucleotide Sequence Databases, were designed. Universal (general) primers were designed to detect all variants of the eae, tir, espA, espB, and espD genes, as well as specific primers for the detection of 16 eae variants ({alpha}1, {alpha}2, ß1, ß2, {gamma}1, {gamma}2/{theta}, {delta}/{kappa}, {epsilon}, {zeta}, {eta}, {iota}, {lambda}, µ, {nu}, {xi}, and o), 4 tir variants ({alpha}1, ß1, {gamma}1, and {gamma}2), 4 espA variants ({alpha}1, ß1, ß2, and {gamma}1), 3 espB variants ({alpha}1, ß1, and {gamma}1), and 3 variants ({alpha}1, ß1, and {gamma}1) of the espD gene (Fig. 1 ; also see Table 1 in the online Data Supplement). Because of the high degree of sequence identity, specific primers could not be designed for PCR typing between eae-{gamma}2 and eae-{theta} genes and between eae-{delta} and eae-{kappa} genes. Because tir, espA, espB, and espD sequences are available from only a limited number of strains, primers could be designed for the detection of only a small number of variants of these LEE genes. Listed in Table 1Up are the 12 different combinations of tir, espA, espB, and espD genes that we have found among the 25 typed strains. In this study, we found that all strains with a specific eae type had the same combination of tir, espA, espB, and espD types. We found homologous gene combinations only in strains with eae-{alpha}1, eae-ß1, and eae-{gamma}1 variants, because all strains possessing these genes had the corresponding {alpha}1, ß1, and {gamma}1 subtypes of tir, espA, espB, and espD by PCR typing.


Figure 1
View larger version (9K):
[in this window]
[in a new window]
 
Figure 1. Genes eae, tir, espA, espD, and espB from the pathogenic island LEE.

Oligonucleotides (TIR-UP and ESPB-DOWN) for LR-PCR are indicated (small arrows). Filled arrowheads indicate the relative location of the oligonucleotide pairs used for universal or strain specific PCR amplification (see Table 1Up ).

stec-epec microarray: a microarray for lee pathogenicity island diversity
We selected oligonucleotide probes for STEC diversity from multiple alignments of sequences of the LEE pathogenicity island genes (see Table 2 and Fig. 1 in the online Data Supplement). Probes for 16 variants of eae, 4 of tir, 4 of espA, 3 of espB, and 3 of espD were synthesized. All probes contained an aliphatic (C6) amine at the 5' end followed by a (dT)10 tail before the specific sequence, which ranged from 18 to 24 nucleotides. Two parallel subarrays were printed in quadruplicate spots: one containing both PCR fragments and specific oligonucleotides as probes (Fig. 2, A and C ), and one containing only the oligonucleotide probes (Fig. 2, B and D ). Although PCR fragments showed extensive cross-reactivity, oligonucleotides gave a high specific hybridization signal when tested against fluorescently labeled PCR-amplified fragments from the corresponding type strain. At least 2 oligonucleotide probes (usually 1 in the forward and 1 in the reverse direction) were tested for their specificity by microarray hybridization. Several sets of probes, such as those shown in Table 2 of the online Data Supplement, were printed in different sets of microarrays to check for their specificity with all strain types. Probes that failed to identify the strain for which they were designed were modified (extending or shortening the sequence) or were fully replaced by a different sequence from other locations on the gene (see Table 2 in the online Data Supplement). At least 1 probe per strain was selected that gave a high specific and intense signal with the corresponding fluorescent PCR-amplified fragment (see Fig. 1 in the online Data Supplement), whereas the remaining probes gave signals that were below the detection limit or were very close to background. Some cross-hybridization was still detected with certain probes, such probe IH2489a-F, which apart of the strong signal with its specific strain (eae-{alpha}2) also gave some signal with strain eae-{nu}. Nevertheless, the difference between the specific vs nonspecific signal intensities was always more than 2-fold (note the saturated spots with eae-{alpha}2), clearly indicating that IH2489a-F probe was specific for the eae-{alpha}2 strain. Genomic DNA from a non–verotoxin-producing E. coli (strain MG1655) and a PCR-amplified fragment from 16S rRNA were used as negative control spots. No signal was detected in the probes when fluorescently labeled genomic DNA from MG1655 was used as target (not shown).


Figure 2
View larger version (32K):
[in this window]
[in a new window]
 
Figure 2. STEC-EPEC microarray showing the results of 2 representative hybridizations.

Fluorescent PCR-amplified fragment eae-{lambda} from type strain 68-4 (A and B) and eae-µ from type strain FV380 (C and D). Specific probes for the strains tested are indicated (white squares). (Bottom), scheme showing the probes spotted on the array: chromosomal DNA from each strain (dotted boxes), PCR-amplified fragments (shaded boxes), and oligonucleotides (open boxes). Subarrays A and C contain all probes, whereas B and D contain only oligonucleotides, with spotting solution on the remaining sites.

testing the stec-epec microarray for several genes
One of the great advantages of DNA microarrays is that they permit screening for up to thousands of different genes or probes simultaneously. For that purpose, samples to be analyzed must contain at least 1 putative target for each probe. Multiplex PCR can in part solve this issue by amplifying 2 to 6 different loci in 1 reaction, so that all PCR products can be checked on the microarray. The use of total chromosomal DNA as fluorescent target clearly overcomes the limitations of multiplex PCR and expands to the genomic level the number of loci to be analyzed. We tested the performance of our STEC microarray, using different methods for target preparation (Fig. 3 ). As expected, PCR-based methods gave stronger and more specific signals for each probe, but they allowed the analysis of only a limited number of genes. For gene clusters such the LEE island, LR-PCR is an interesting alternative because all genes tested have the same number of target molecules, avoiding unequal signals resulting from differences in the amplification efficiencies, which can occur with multiplex PCR. The use of genomic DNA as target, even when it gave a lower signal and higher background, allowed us to simultaneously detect and identify all gene variants for a certain strain or sample (Fig. 3 ; also see Fig. 2 in the online Data Supplement). Frequently, the amount of starting DNA is a limiting factor; for example, in environmental, clinical, or veterinary samples. In these cases, chromosomal DNA amplification techniques with enzymes such as phage {phi}29 DNA polymerase are extremely useful. We used this technique to amplify total DNA (initial amount, 10 pg) of chromosomal DNA from strains FV3671 (eae-{eta}) and FV3676 (eae-{iota}); we then fluorescently labeled 2 µg of the products (see Materials and Methods) and incubated the labeled products with the microarray (Fig. 3 ). The result was similar to that obtained with chromosomal DNA without amplification. Use of both amplified and nonamplified chromosomal DNA enabled detection of all genes and the specific eae and tir variants, although it failed with espADB-specific probes. In those cases, we redesigned and synthesized new probes until good signals were obtained (see Fig. 2 in the online Data Supplement). Note that those spots containing chromosomal DNA from the negative control strain and 16S rRNA gene (see Fig. 3 , bottom left of the arrays), gave a positive signal only when we used fluorescently labeled chromosomal DNA (amplified or not) for hybridization.


Figure 3
View larger version (31K):
[in this window]
[in a new window]
 
Figure 3. STEC-EPEC microarray and different methods for the simultaneous detection of gene variants from several genes.

Comparison between single PCR, multiplex PCR, LR-PCR, genomic DNA, and MDA amplification with µ29 DNA polymerase in a comparative analysis with 2 strains: FV3671 (eae-{eta}) and FV3676 (eae-{iota}). Specific probes are indicated (white rectangles). Other positive signals correspond to universal probes or controls, such as the chromosomal DNA MG1655 and the 16S rRNA gene, which gave a positive signal only when chromosomal DNA was used for hybridization. The arrays contain the oligonucleotide probes shown in the schematic (left), plus chromosomal DNA from the negative strain (MG1655) and 16S rRNA gene. Shaded boxes indicate the specific probes [white squares in the array images (right)]. Empty boxes indicate that no probes were printed in these positions.

determining pathotype with the stec-epec microarray in a single hybridization experiment
We also tested the specificity of the probes for all strain types, using chromosomal DNA (see Fig. 2 in the online Data Supplement). As mentioned above, some probes were redesigned or newly synthesized from a different location of the gene (see Table 2 in the online Data Supplement). All gene variants were simultaneously checked for each strain, permitting us to define a gene pathogenic pattern (pathotype) characteristic for each STEC strain. A sort of "barcode" can be obtained for each strain after hybridization, so that a unique barcode identifies a unique strain. Several oligonucleotides that were designed as universal primers for PCR amplification (EAE-F, TIR-A, TIR-B, or ESPA-1) failed in some hybridizations with chromosomal DNA (see Fig. 2 in the online Data Supplement), indicating that further optimization for microarrays is necessary. This is not a main issue because longer oligonucleotides or PCR-amplified fragments can be used as universal probes. The fragmentation of genomic DNA by ultrasonication to obtain a mean size of 2 to 4 kb before labeling was very reproducible (see Materials and Methods) while avoiding cumbersome procedures that use enzymatic digestions.


   Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The differentiation of eae, tir, espA, espD, and espB gene variants of the LEE pathogenicity island represents an important tool for STEC and EPEC typing in routine diagnostics as well as in pathogenesis, epidemiologic, clonal, and immunologic studies. In this work, we have elaborated a TS-PCR scheme for amplification and typing of 16 variants of the eae gene ({alpha}1, {alpha}2, ß1, ß2, {gamma}1, {gamma}2/{theta}, {delta}/{kappa}, {epsilon}, {zeta}, {eta}, {iota}, {lambda}, µ,{nu}, {xi}, and o), 4 variants of the tir gene ({alpha}1, ß1, {gamma}1, and {gamma}2/{theta}), 4 variants of the espA gene ({alpha}1, ß1, ß2, and {gamma}1), 3 variants of the espB gene ({alpha}1, ß1, and {gamma}1), and 3 variants of the espD gene ({alpha}1, ß1, {gamma}1). We also constructed an oligonucleotide microarray (STEC-EPEC microarray) for the detection and characterization of these genes.

China et al. (37) and Goffaux et al.(29) identified 3 subtypes of the tir ({alpha}, ß, and {gamma}), espA ({alpha}, ß, and {gamma}), espB ({alpha}, ß, and {gamma}), and espD ({alpha}, ß, and {gamma}) LEE genes. They found only 4 LEE profiles in human and bovine AEEC strains: eae-{alpha}/tir-{alpha}/espA-{alpha}/espB-{alpha}/espD-{alpha}, eae-ß/tir-ß/espA-ß/espB-ß/espD-ß, eae-{gamma}/tir-{alpha}/espA-{alpha}/espB-{alpha}/espD-{alpha}, and eae-{gamma}/tir-{gamma}/espA-{gamma}/espB-{gamma}/espD-{gamma}. Nielsen and Andersen (38) identified 4 subtypes of tir ({alpha}, ß, {gamma}, and {theta}), 3 subtypes for espD ({alpha}, ß, and {gamma}), and a total of 7 LEE profiles (eae-{alpha}/tir-{alpha}/espD-{alpha}, eae-ß/tir-ß/espD-ß, eae-{gamma}/tir-{gamma}/espD-{gamma}, eae-{theta}/tir-{theta}/espD-NT, eae-{delta}/tir-{alpha}/espD-{alpha}, eae-{epsilon}/tir-ß/espD-ß, and eae-{zeta}/tir-{alpha}/espD-NT). In the present study, we identified 4 variants of tir and 3 variants each of espA, espB, and espD, as well as 12 combinations of these LEE genes. We found homologous combinations or associations [in the sense described by China et al. (37)] only in strains with eae-{alpha}1, eae-ß1, and eae-{gamma}1 genes because all strains possessing these genes had the corresponding {alpha}1, ß1, and {gamma}1 subtypes of tir, espA, espB, and espD. As in previous studies (29)(37)(38), we found that the strains with a specific eae variant showed the same combination of tir and esp genes. After sequence analysis of the amplification products, we also observed a homologous association with tir and esp genes in strains with eae-{gamma}2/{theta} and eae-o (data not shown). The nucleotide sequence of the amplification products of nontypeable tir, espA, espB, and espD genes confirmed that these strains possessed new variants of these LEE genes (data not shown).

The use of PCR-amplified fragments as probes in the microarray enabled detection and differentiation of genes with very different sequences, but use of these fragments produced a strong cross-reaction between different alleles of the same locus. It is necessary to focus the probe to a shorter and less complex region of the gene by use of synthetic oligonucleotides. The differences in nucleotide sequences among eae, tir, espA, espD, and espB gene variants were high enough to allow us to design specific probes for oligonucleotide microarrays. Some of them gave good sensitivity and specificity, but others had to be redesigned to achieve the desired results. For most of the gene variants, we designed 2 specific oligonucleotides, both of which gave good signals except if one of them was located at one end of the labeled target. In that case, the hybridized complex was not sufficiently stable and could not be detected. For best performance, a specific oligonucleotide must be located in the inner part the target sequence. Our STEC-EPEC microarray is the result of empirical tests for many probes to get the best combination in terms of specificity. Hybridization conditions such temperature, buffer composition, or target length may be modified to obtain higher signal intensities or better differentiation between strains.

Oligonucleotide microarrays allow the detection and differentiation of not only different virulence and non-virulence genes, but also multiple alleles of the same gene in a single hybridization event. For linked loci such as those of the LEE pathogenicity island, we found that use of LR-PCR for target amplification and labeling offered advantages compared with multiplex PCR in the sense that LR-PCR was more reproducible and gave smaller differences among different strains. Moreover, the possibility of having all genes in the same fragment ensures the same copy number for all of them. In addition, we showed that the use of chromosomal DNA as the hybridization target enables whole pathotyping, not only because many genes can be checked simultaneously, but also because their variants can be identified. Genomic DNA amplification techniques such MDA are suitable for use when the amount of the initial sample is limited, as happens for clinical or environmental samples. The proposed method for chromosomal DNA fragmentation by ultrasonication before labeling is rapid and reproducible, and it avoids the need for enzymatic digestions and procedures to concentrate DNA.

In conclusion, the combination of MDA, ultrasonic fragmentation of DNA, fluorescent labeling, and oligonucleotide microarray hybridization can simplify and improve the analysis of clinical, veterinary, or environmental samples.


   Acknowledgments
 
We thank L.G. Giugliano (Brasília, Brazil), F. Schelotto and G. Varela (Montevideo, Uruguay), F. rskov and I. rskov (Copenhagen, Denmark), H. Schmidt (Wüzburg, Germany), H. Karch (Münster, Germany), E. Oswald (Toulouse, France), Y. Bertin (Clermont-Ferrand-Theix, France), and T.S. Whittam (Michigan) for generously providing strains. We also thank Monserrat Lamela for skillful technical assistance. This work was supported by grants from the Fondo de Investigación Sanitaria of Instituto de Salud Carlos III of Spanish Ministerio de Sanidad (grant FIS G03-025-COLIRED-O157), and from the Xunta de Galicia (grants PGIDIT02BTF26101PR and PGIDIT04RAG261014PR). P.G. is a fellow on grant FIS G03-025. M.M. and C.B. have a contract from Instituto Nacional de Técnica Aeroespacial (INTA), and V.P. has a "Ramón y Cajal" contract from the Spanish Ministerio de Educación y Ciencia.


   Footnotes
 
1 Nonstandard abbreviations: STEC, Shiga toxin–producing Escherichia coli; EPEC, enteropathogenic E. coli; A/E, attaching and effacing; LEE, locus of enterocyte effacement; TS-PCR; type-specific PCR; LR-PCR, long-range PCR; and MDA, multiple displacement amplification.


   References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Blanco JE, Blanco M, Alonso MP, Mora A, Dahbi G, Coira MA, et al. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999. J Clin Microbiol 2004;42:311-319.[Abstract/Free Full Text]
  2. Blanco M, Blanco J, Blanco JE, Ramos J. Enterotoxigenic, verotoxigenic, and necrotoxigenic Escherichia coli isolated from cattle in Spain. Am J Vet Res 1993;54:1446-1451.[ISI][Medline] [Order article via Infotrieve]
  3. Blanco M, Blanco JE, Blanco J, González EA, Mora A, Prado C, et al. Prevalence and characteristics of Escherichia coli serotype O157:H7 and other verotoxin-producing E. coli in healthy cattle. Epidemiol Infect 1996;117:251-257.[Medline] [Order article via Infotrieve]
  4. Blanco M, Blanco JE, Mora A, Dahbi G, Alonso MP, González EA, et al. Serotypes, virulence genes and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from cattle in Spain and identification of a new intimin variant gene (eae-{xi}). J Clin Microbiol 2004;42:645-651.[Abstract/Free Full Text]
  5. Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev 1989;2:5-38.
  6. Mora A, Blanco M, Blanco JE, Alonso MP, Dhabi G, Thomson-Carter F, et al. Phage types and genotypes of Shiga toxin-producing Escherichia coli O157:H7 Isolates from humans and animals in Spain: identification and characterization of two predominating phage types (PT2 and PT8). J Clin Microbiol 2004;42:4007-4015.[Abstract/Free Full Text]
  7. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998;11:142-201.[Abstract/Free Full Text]
  8. Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998;11:450-479.[Abstract/Free Full Text]
  9. Stephan R, Borel N, Zweifel C, Blanco M, Blanco JE. First isolation and further characterization of enteropathogenic Escherichia coli (EPEC) O157:H45 strains from cattle. BMC Microbiol 2004;4:10.[CrossRef][Medline] [Order article via Infotrieve]
  10. Aidar L, Penteado AS, Trabulsi LR, Blanco JE, Blanco M, Blanco J, et al. Subtypes of intimin among non-toxigenic Escherichia coli from diarrheic calves in Brazil. Can J Vet Res 2000;64:15-20.[ISI][Medline] [Order article via Infotrieve]
  11. Blanco JE, Blanco M, Blanco J, Mora A, Balaguer L, Mouriño M, et al. O serogroups, biotypes and eae genes in Escherichia coli strains isolated from diarrheic and healthy rabbits. J Clin Microbiol 1996;34:3101-3107.[Abstract]
  12. Blanco M, Blanco JE, Blanco J, Carvalho VM, Lopes-Onuma D, Pestana de Castro AF. Typing of intimin (eae) genes in attaching and effacing Escherichia coli strains from monkeys. J Clin Microbiol 2004;42:1382-1383.[Free Full Text]
  13. Carvalho VM, Gyles CL, Ziebell K, Ribeiro MA, Catao-Dias JL, Sinhorini IL, et al. Characterization of monkey enteropathogenic Escherichia coli (EPEC) and human typical and atypical EPEC serotype isolates from neotropical nonhuman primates. J Clin Microbiol 2003;41:1225-1234.[Abstract/Free Full Text]
  14. Janke BH, Francis DH, Collins JE, Libal MC, Zeman DH, Johnson DD. Attaching and effacing Escherichia coli infections in calves, pigs, lambs, and dogs. J Vet Diagn Investig 1989;1:6-11.[Abstract/Free Full Text]
  15. Knutton S. Attaching and effacing E. coli. Gyles CL eds. Escherichia coli in domestic animals and humans 1994:567-591 CAB International Wallingford. .
  16. Torres ME, Pírez MC, Schelotto F, Varela G, Parodi V, Allende F, et al. Etiology of children’s diarrhea in Montevideo, Uruguay: associated pathogens and unusual isolates. J Clin Microbiol 2001;39:2134-2139.[Abstract/Free Full Text]
  17. Trabulsi LR, Keller R, Gomes TAT. Typical and atypical enteropathogenic Escherichia coli. Emerg Infect Dis 2002;8:508-513.[ISI][Medline] [Order article via Infotrieve]
  18. Tzipori S, Gunzer F, Donnenberg MS, de-Montigny L, Kaper JB, Donohue-Rolfe A. The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohaemorrhagic Escherichia coli infection. Infect Immun 1995;63:3621-3627.[Abstract]
  19. Adu-Bobie J, Frankel G, Bain C, Goncalves AG, Trabulsi LR, Douce G, et al. Detection of intimins {alpha}, ß, {gamma}, {delta}, and four intimin derivatives expressed by attaching and effacing microbial pathogens. J Clin Microbiol 1998;36:662-668.[Abstract/Free Full Text]
  20. Batisson I, Guimond MP, Girard F, An H, Zhu C, Oswald E, et al. Characterization of the novel factor paa involved in the early steps of the adhesion mechanism of attaching and effacing Escherichia coli. Infect Immun 2003;71:4516-4525.[Abstract/Free Full Text]
  21. Beutin L, Marches O, Bettelheim KA, Gleier K, Zimmermann S, Schmidt H, et al. Hep-2 cell adherence, actin aggregation, and intimin types of attaching and effacing Escherichia coli strains isolated from healthy infants in Germany and Australia. Infect Immun 2003;71:3995-4002.[Abstract/Free Full Text]
  22. Kaper JB, Elliott S, Sperandio V, Perna NT, Mayhew GF, Blattner FR. Attaching and effacing intestinal histopathology and the locus of enterocyte effacement. Kaper JB O’Brien AD eds. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains 1998:163-182 American Society for Microbiology Washington DC. .
  23. Finlay BB, Rosenshine I, Donnenberg MS, Kaper JB. Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells. Infect Immun 1992;60:2541-2543.[Abstract/Free Full Text]
  24. Donnenberg MS, Lai LC, Taylor KA. The locus of enterocyte effacement pathogenicity island of enteropathogenic Escherichia coli encodes secretion functions and remnants of transposons at its extreme right end. Gene 1997;184:107-114.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  25. Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 1990;87:7839-7843.[Abstract/Free Full Text]
  26. Jores J, Rumer L, Kiessling S, Kaper JB, Wieler LH. A novel locus of enterocyte effacement (LEE) pathogenicity island inserted at pheV in bovine Shiga toxin producing Escherichia coli strain O103:H2. FEMS Microbiol Lett 2001;204:75-79.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  27. Perna NT, Mayhew GF, Posfai G, Elliot S, Donnenberg MS, Kaper JB, et al. Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7. Infect Immun 1998;66:3810-3817.[Abstract/Free Full Text]
  28. Elliot SJ, Hutcheson SW, Dubois MS, Mellies JL, Wainwright LA, Batchelor M, et al. Identification of CesT, a chaperone for the type III secretion of Tir in enteropathogenic Escherichia coli. Mol Microbiol 1999;33:1176-1189.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  29. Goffaux F, China B, Mainil J. Organisation and in vitro expression of esp genes of the LEE (locus of enterocyte effacement) of bovine enteropathogenic and enterohemorrhagic Escherichia coli. Vet Microbiol 2001;83:275-286.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  30. Paton AW, Manning PA, Woodrow MC, Paton JC. Translocated intimin receptors (Tir) of Shiga-toxigenic Escherichia coli isolates belonging to serogroups O26, O111, and O157 react with sera from patients with hemolytic-uremic syndrome and exhibit market sequence heterogeneity. Infect Immun 1998;66:5580-5586.[Abstract/Free Full Text]
  31. Oswald E, Schmidt H, Morabito S, Karch H, Marches O, Caprioli A. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect Immun 2000;68:64-71.[Abstract/Free Full Text]
  32. Zhang WL, Köhler B, Oswald E, Beutin L, Karch H, Morabito S, et al. Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains. J Clin Microbiol 2002;40:4486-4492.[Abstract/Free Full Text]
  33. Frankel G, Candy DCA, Fabiani E, Adu-Bobie J, Gil S, Novakova M, et al. Molecular characterization of a carboxy-terminal eukaryotic-cell-binding domain of intimin from enteropathogenic Escherichia coli. Infect Immun 1995;63:4323-4328.[Abstract]
  34. Phillips AD, Frankel G. Intimin-mediated tissue specificity in enteropathogenic Escherichia coli interaction with human intestinal organ cultures. J Infect Dis 2000;181:1496-1500.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  35. Fitzhenry RJ, Pickard DJ, Hartland EL, Reece S, Dougan G, Phillips AD, et al. Intimin type influences the site of human intestinal mucosal colonization by enterohaemorrhagic Escherichia coli O157:H7. Gut 2002;50:180-185.[Abstract/Free Full Text]
  36. Tarr CL, Whittam S. Molecular evolution of the intimin gene in O111 clones of pathogenic Escherichia coli. J Bacteriol 2002;184:479-487.[Abstract/Free Full Text]
  37. China B, Goffaux F, Pirson V, Mainil J. Comparison of eae, tir, espA and espB genes of bovine and human attaching and effacing Escherichia coli by multiplex polymerase chain reaction. FEMS Microbiol Lett 1999;178:177-182.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  38. Nielsen EM, Andersen MT. Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5'nuclease PCR assay. J Clin Microbiol 2003;41:2884-2893.[Abstract/Free Full Text]
  39. Blanco M, Paloda NL, Kruger A, Sanz ME, Blanco JE, González EA, et al. Virulence genes and intimin types of Shiga-toxin-producing Escherichia coli isolated from cattle and beef products in Argentina. Int Microbiol 2004;7:269-276.[Medline] [Order article via Infotrieve]
  40. Call DR, Brockman FJ, Chandler DP. Detecting and genotyping Escherichia coli O157:H7 using multiplexed PCR and nucleic acid microarrays. Int J Food Microbiol 2001;67:71-80.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  41. Cebula TA, Payne WL, Feng P. Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J Clin Microbiol 1995;33:248-250.[Abstract]
  42. Chizhikov V, Rasooly A, Chumakov K, Levy DD. Microarray analysis of microbial virulence factors. Appl Environ Microbiol 2001;67:3258-3263.[Abstract/Free Full Text]
  43. Cho JC, Tiedje JM. Bacterial species determination from DNA-DNA hybridization by using genome fragments and DNA microarrays. Appl Environ Microbiol 2001;67:3677-3682.[Abstract/Free Full Text]
  44. Dobrindt U, Agerer F, Michaelis K, Janka A, Buchrieser C, Samuelson M, et al. Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays. J Bacteriol 2003;185:1831-1840.[Abstract/Free Full Text]
  45. Li J, Chen S, Evans DH. Typing and subtyping influenza virus using DNA microarrays and multiplex reverse transcriptase PCR. J Clin Microbiol 2001;39:696-704.[Abstract/Free Full Text]
  46. Murray AE, Lies D, Li G, Nealson K, Zhou J, Tiedje JM. DNA/DNA hybridization to microarrays reveals gene-specific differences between closely related microbial genomes. Proc Natl Acad Sci U S A 2001;98:9853-9858.[Abstract/Free Full Text]
  47. Wu CF, Valdes JJ, Bentley WE, Sekowski JW. DNA microarray for discrimination between pathogenic 0157:H7 EDL933 and non-pathogenic Escherichia coli strains. Biosens Bioelectron 2003;19:1-8.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  48. Chen S, Zhao S, McDermott PF, Schroeder CM, White DG, Meng J. A DNA microarray for identification of virulence and antimicrobial resistance genes in Salmonella serovars and Escherichia coli. Mol Cell Probes 2005;19:195-201.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  49. Bekal S, Brousseau R, Masson L, Prefontaine G, Fairbrother J, Harel J. Rapid identification of Escherichia coli pathotypes by virulence gene detection with DNA microarrays. J Clin Microbiol 2003;41:2113-2125.[Abstract/Free Full Text]
  50. Guinée PAM, Jansen WH, Wadström T, Sellwood R. Escherichia coli associated with neonatal diarrhea in piglets and calves. Curr Top Vet Anim Sci 1981;13:126-162.
  51. Gunzburg ST, Tornieporth NG, Riley LW. Identification of enteropathogenic Escherichia coli by PCR-based detection of the bundle-forming pilus gene. J Clin Microbiol 1995;33:1375-1377.[Abstract]
  52. Blanco M, Blanco JE, Mora A, Rey J, Alonso JM, Hermoso M, et al. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from healthy sheep in Spain. J Clin Microbiol 2003;41:1351-1365.[Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
Vet Rec.Home page
Y. Ha, S. K. Ha, Y. H. Lee, D. Kim, S. Chae, C. H. Kim, K. K. Ahn, O. Kim, and C. Chae
Prevalence of tir gene subtypes in Escherichia coli isolates from pigs
Vet Rec., October 4, 2008; 163(14): 424 - 425.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
J. E. Afset, E. Anderssen, G. Bruant, J. Harel, L. Wieler, and K. Bergh
Phylogenetic Backgrounds and Virulence Profiles of Atypical Enteropathogenic Escherichia coli Strains from a Case-Control Study Using Multilocus Sequence Typing and DNA Microarray Analysis
J. Clin. Microbiol., July 1, 2008; 46(7): 2280 - 2290.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. Ito, M. Iida, M. Yamazaki, K. Moriya, S. Moroishi, J. Yatsuyanagi, T. Kurazono, N. Hiruta, and O.-A. Ratchtrachenchai
Intimin Types Determined by Heteroduplex Mobility Assay of Intimin Gene (eae)-Positive Escherichia coli Strains
J. Clin. Microbiol., March 1, 2007; 45(3): 1038 - 1041.
[Abstract] [Full Text] [PDF]